Pharmaceutical administration practice during control and treatment of COVID-19
10.3760/cma.j.cn112225-20200302-00440
- VernacularTitle:新冠肺炎患者定点收治医院药事管理工作实践
- Author:
Xiulan LIU
1
;
Yi LIU
;
Lin QIU
;
Pan LUO
;
Jingjin JIN
;
Jianling ZHENG
;
Xuepeng GONG
;
Dong LIU
;
Juan LI
Author Information
1. 华中科技大学同济医学院附属同济医院药学部，武汉 430030
- From:
Chinese Journal of Hospital Administration
2020;36(4):324-327
- CountryChina
- Language:Chinese
-
Abstract:
In designated hospitals for critical patients with COVID-19 in Wuhan, time-efficient pharmaceutical emergency protection system was of great significance for epidemic prevention. Described in the paper are measures taken by the pharmaceutical department of the hospital as follows. These measures include launching an emergency response mechanism, formulating a catalogue of COVID-19 key therapeutic drugs, urgently purchasing therapeutic drugs, transforming the processes of emergency pharmacy, establishing a drug donation management system, building a COVID-19 pharmaceutical care team, and setting up a " cloud pharmacy" to meet the drug needs of patients with non-COVID-19 chronic diseases, in addition to strengthening personnel protection of pharmacists. During such an epidemic, the pharmacy administration works in a professional, comprehensive, complex and systematic emergency program, which guaranteed the safety of drug supply, medication and enabled the treatment to be carried out in an orderly manner.
